AP2913A - Treatment of HIV - Google Patents

Treatment of HIV

Info

Publication number: AP2913A
Authority: AP; ARIPO
Prior art keywords: hiv; treatment
Prior art date: 2006-01-06

Application number

AP2008004560A

Other languages

English (en)

Other versions

AP2008004560A0 (en

Inventor

Deirdre Mcintosh

Original Assignee

Aimsco Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-06

Filing date

2007-01-05

Publication date

2014-05-31

2007-01-05 Application filed by Aimsco Ltd filed Critical Aimsco Ltd

2008-08-31 Publication of AP2008004560A0 publication Critical patent/AP2008004560A0/xx

2014-05-31 Application granted granted Critical

2014-05-31 Publication of AP2913A publication Critical patent/AP2913A/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/35—Corticotropin [ACTH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Marine Sciences & Fisheries (AREA)
Virology (AREA)
Cell Biology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AP2008004560A 2006-01-06 2007-01-05 Treatment of HIV AP2913A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0600202.6A GB0600202D0 (en)	2006-01-06	2006-01-06	Treatment of HIV
PCT/GB2007/050006 WO2007077465A2 (en)	2006-01-06	2007-01-05	Treatment of hiv

Publications (2)

Publication Number	Publication Date
AP2008004560A0 AP2008004560A0 (en)	2008-08-31
AP2913A true AP2913A (en)	2014-05-31

Family

ID=35911459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2008004560A AP2913A (en)	2006-01-06	2007-01-05	Treatment of HIV

Country Status (16)

Country	Link
US (4)	US20090291060A1 (xx)
EP (1)	EP1968624A2 (xx)
JP (1)	JP5180095B2 (xx)
KR (2)	KR20080098488A (xx)
CN (1)	CN101394862A (xx)
AP (1)	AP2913A (xx)
AU (1)	AU2007203991B2 (xx)
BR (1)	BRPI0706311A2 (xx)
CA (1)	CA2635562A1 (xx)
EA (1)	EA015924B1 (xx)
GB (1)	GB0600202D0 (xx)
IL (1)	IL192618A (xx)
MX (1)	MX2008008768A (xx)
NZ (1)	NZ569604A (xx)
WO (1)	WO2007077465A2 (xx)
ZA (1)	ZA200806505B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010054446A1 (en) *	2008-11-11	2010-05-20	Ademovic Zlatko	Combination of two or more peptides in a single stable lyophilized pharmaceutical compound
JP5717030B2 (ja) *	2009-02-24	2015-05-13	学校法人金沢医科大学	有核赤血球の脱核方法及び脱核誘導剤
WO2014001749A1 (en)	2012-06-25	2014-01-03	Aimsco Limited	Formulation comprising crh and alpha - 2 - immunoglobulin
US20130344102A1 (en) *	2012-06-25	2013-12-26	Aimsco Limited	Formulation
GB201617175D0 (en) *	2016-10-10	2016-11-23	Iconic Intellectual Property Limited	Assay
KR20210137535A (ko) *	2019-03-13	2021-11-17	아다미스 파마슈티칼스 코포레이션	β-엔돌핀 및 부신피질자극 호르몬의 조합을 포함하는 제제
US11285192B2 (en) *	2019-03-13	2022-03-29	Adamis Pharmaceuticals Corporation	Formulation including a combination of beta-endorphin and adrenocorticotropic hormone

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006021814A2 (en) *	2004-07-08	2006-03-02	Aimsco Limited	Medicament

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4801612A (en) *	1986-07-03	1989-01-31	Regents Of The University Of California	Method of inhibiting inflammatory response
US5137871A (en) *	1989-07-28	1992-08-11	Regents Of The University Of California	Treatment to reduce edema for brain and musculature injuries
CN1301729A (zh) *	1999-12-24	2001-07-04	上海博德基因开发有限公司	一种新的多肽——促肾上腺皮质激素释放因子13和编码这种多肽的多核苷酸
AU2001275696A1 (en) *	2000-07-21	2002-02-05	Ice Biologics Limited	Therapeutic agent
CN1361180A (zh) *	2000-12-26	2002-07-31	上海博德基因开发有限公司	一种新的多肽——促肾上腺皮质激素释放因子8.8和编码这种多肽的多核苷酸
DE50201566D1 (de) *	2001-02-24	2004-12-23	Mologen Ag	Beta-endorphin / crf - gentherapie zur lokalen schmerzbekämpfung
WO2003064472A2 (en) *	2002-01-28	2003-08-07	Aimsco Limited	Treatment of ms with goat serum
WO2003004049A2 (en) *	2001-07-02	2003-01-16	Aimsco Limited	Use of polyclonal anti-hiv goat serum as a therapeutic agent
GB0509052D0 (en) *	2005-05-04	2005-06-08	Aimsco Ltd	Combination therapy

2006
- 2006-01-06 GB GBGB0600202.6A patent/GB0600202D0/en not_active Ceased
2007
- 2007-01-05 US US12/087,442 patent/US20090291060A1/en not_active Abandoned
- 2007-01-05 EP EP07700413A patent/EP1968624A2/en not_active Withdrawn
- 2007-01-05 NZ NZ569604A patent/NZ569604A/en not_active IP Right Cessation
- 2007-01-05 WO PCT/GB2007/050006 patent/WO2007077465A2/en active Application Filing
- 2007-01-05 KR KR1020087019225A patent/KR20080098488A/ko not_active Application Discontinuation
- 2007-01-05 CA CA002635562A patent/CA2635562A1/en not_active Abandoned
- 2007-01-05 MX MX2008008768A patent/MX2008008768A/es active IP Right Grant
- 2007-01-05 CN CNA2007800077425A patent/CN101394862A/zh active Pending
- 2007-01-05 EA EA200870158A patent/EA015924B1/ru not_active IP Right Cessation
- 2007-01-05 JP JP2008549065A patent/JP5180095B2/ja not_active Expired - Fee Related
- 2007-01-05 AU AU2007203991A patent/AU2007203991B2/en not_active Ceased
- 2007-01-05 AP AP2008004560A patent/AP2913A/xx active
- 2007-01-05 BR BRPI0706311-3A patent/BRPI0706311A2/pt not_active IP Right Cessation
- 2007-01-05 KR KR1020147023081A patent/KR20140114443A/ko not_active Application Discontinuation
2008
- 2008-07-03 IL IL192618A patent/IL192618A/en active IP Right Grant
- 2008-07-25 ZA ZA200806505A patent/ZA200806505B/xx unknown
2012
- 2012-04-19 US US13/450,597 patent/US20120208745A1/en not_active Abandoned
- 2012-12-04 US US13/693,174 patent/US20130210710A1/en not_active Abandoned
2013
- 2013-11-14 US US14/080,693 patent/US20140072530A1/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006021814A2 (en) *	2004-07-08	2006-03-02	Aimsco Limited	Medicament

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADDO E. ET AL.: "ACTH-inosine pranobex in the treatment of AIDS. Encouraging results". THE WEST INDIAN MEDICAL JOURNAL SEP 1989, vol. 38, no. 3, September 1989 (1989-09), pages 142-147 *
BARCELLINI W. ET AL.: "Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes". JOURNAL OF LEUKOCYTE BIOLOGY NOV 2000, vol. 68, no. 5, November 2000 (2000-11), pages 693-699 *
CATANIA A. ET AL.: "Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients". PEPTIDES 1998, vol. 19, no. 6, 1998, pages 1099-1104 *
CATANIA A. ET AL.: "Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome". CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY JAN 1993, vol. 66, no. 1, January 1993 (1993-01), pages 73-79 *
DATABASE WPI Week 200145, Derwent Publications Ltd., London, GB; AN 2001-425635 *
DATABASE WPI Week 200253, Derwent Publications Ltd., London, GB; AN 2002-500761 *

Also Published As

Publication number	Publication date
CA2635562A1 (en)	2007-07-12
ZA200806505B (en)	2009-05-27
CN101394862A (zh)	2009-03-25
EA015924B1 (ru)	2011-12-30
JP5180095B2 (ja)	2013-04-10
KR20140114443A (ko)	2014-09-26
BRPI0706311A2 (pt)	2011-03-22
IL192618A0 (en)	2009-02-11
JP2009522345A (ja)	2009-06-11
US20140072530A1 (en)	2014-03-13
EA200870158A1 (ru)	2008-12-30
IL192618A (en)	2012-06-28
AP2008004560A0 (en)	2008-08-31
MX2008008768A (es)	2008-09-11
WO2007077465A3 (en)	2007-11-08
EP1968624A2 (en)	2008-09-17
GB0600202D0 (en)	2006-02-15
AU2007203991B2 (en)	2013-01-17
US20090291060A1 (en)	2009-11-26
AU2007203991A1 (en)	2007-07-12
US20130210710A1 (en)	2013-08-15
NZ569604A (en)	2011-01-28
KR20080098488A (ko)	2008-11-10
US20120208745A1 (en)	2012-08-16
WO2007077465A2 (en)	2007-07-12

Publication	Publication Date	Title
EP2068864A4 (en)	2010-01-13	THERAPEUTIC USES OF UROLITHINS
GB0610867D0 (en)	2006-07-12	Treatment of pain
GB0602178D0 (en)	2006-03-15	Therapeutic treatment
GB0624874D0 (en)	2007-01-24	Treatment
IL193748A0 (en)	2009-08-03	Treatment of pain
GB0600692D0 (en)	2006-02-22	Well treatment
GB0608655D0 (en)	2006-06-14	Therapeutic Treatment
GB0602768D0 (en)	2006-03-22	Treatment of muscular dystrophy
GB0619500D0 (en)	2006-11-08	Treatment of fibrosis
ZA200806505B (en)	2009-05-27	Treatment of HIV
ZA201000225B (en)	2011-03-30	Treatment of depression
EP2184353A4 (en)	2010-09-08	TREATMENT OF INFLUENZA
GB0610909D0 (en)	2006-07-12	Therapeutic treatment
ZA200901452B (en)	2010-04-28	Treatment of vertigo with acetyl-L-leucine
GB0607952D0 (en)	2006-05-31	Novel treatment
GB0610868D0 (en)	2006-07-12	Treatment of pain
GB0723100D0 (en)	2008-01-02	Treatment of HFnEF
EP2164494A4 (en)	2010-06-02	Methods of Treatment
GB0604460D0 (en)	2006-04-12	Treatment
GB0623740D0 (en)	2007-01-10	Treatment of disease
GB0616450D0 (en)	2006-09-27	Treatment of pain
GB0602767D0 (en)	2006-03-22	Treatment of muscular dystrophy
GB0602857D0 (en)	2006-03-22	The treatment of sialorrhoea
GB0624439D0 (en)	2007-01-17	Technique for treatment of gall-and kidney-stones
GB0610376D0 (en)	2006-07-05	Therapeutic treatment